Senseonics Holdings, Inc. announced the closing of local asset purchase agreements to acquire Eversense CGM activities in Germany, Spain, Sweden, and Italy from Ascensia Diabetes Care Holdings AG. The closings occurred on June 1 and June 8, 2026, with an effective date of June 1, 2026, for finance and accounting purposes.
